EMA Authorised: Selincro (nalmefene hydrochloride dihydrate) — H. Lundbeck A/S

View source ↗

Summary

The European Medicines Agency authorised Selincro (nalmefene hydrochloride dihydrate) by H. Lundbeck A/S for alcohol-related disorders, including reducing alcoh…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Dependence

Drugs mentioned

• Selincro (nalmefene hydrochloride dihydrate)

Snippet

Status: Authorised. Therapeutic area: Alcohol-Related Disorders. MAH: H. Lundbeck A/S. Decision date: 07/10/2025